Sobi has a diversified and growth-oriented commercial product portfolio within three business lines: Core Products, Partner Products and ReFacto Manufacturing.
Core Products
These are proprietary products or products where
Sobi has global or regional rights.
Read more
Partner Products
Partner Products comprise about 40 products which are commercialized on behalf of specialty and rare disease partner companies.
Read more
ReFacto Manufacturing
Sobi is the global supplier of the drug substance for ReFacto AF®/XYNTHA®, a drug sold by Pfizer for the treatment of hemophilia A.
Read more